No, this is neither "profit taking," not "rebalancing." What a strange, self-defeating way to do either. This is something else. The ownership of this company is changing hands and not for the last time. This is a biotech Tesla stock, as it's called now by some old timers at SA and a fight for it will be bloody.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.